Medpace Holdings, Inc. (MEDP)
674.18
-2.59
(-0.38%)
USD |
NASDAQ |
Oct 27, 10:31
Medpace Holdings Enterprise Value : 18.35B for Oct. 26, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 26, 2026 | 18.35B |
| October 23, 2026 | 18.13B |
| October 22, 2026 | 17.71B |
| October 21, 2026 | 17.95B |
| October 20, 2026 | 16.83B |
| October 19, 2026 | 16.75B |
| October 16, 2026 | 16.72B |
| October 15, 2026 | 17.00B |
| October 14, 2026 | 16.67B |
| October 13, 2026 | 16.48B |
| October 12, 2026 | 16.76B |
| October 09, 2026 | 16.54B |
| October 08, 2026 | 16.28B |
| October 07, 2026 | 16.32B |
| October 06, 2026 | 16.29B |
| October 05, 2026 | 16.78B |
| October 02, 2026 | 16.19B |
| October 01, 2026 | 16.15B |
| September 30, 2026 | 16.88B |
| September 29, 2026 | 16.96B |
| September 28, 2026 | 16.79B |
| September 25, 2026 | 16.87B |
| September 24, 2026 | 16.92B |
| September 23, 2026 | 16.82B |
| September 22, 2026 | 17.19B |
| Date | Value |
|---|---|
| September 21, 2026 | 17.02B |
| September 18, 2026 | 16.69B |
| September 17, 2026 | 16.77B |
| September 16, 2026 | 16.80B |
| September 15, 2026 | 16.92B |
| September 14, 2026 | 16.22B |
| September 11, 2026 | 16.00B |
| September 10, 2026 | 15.88B |
| September 09, 2026 | 15.96B |
| September 08, 2026 | 16.09B |
| September 04, 2026 | 16.10B |
| September 03, 2026 | 16.16B |
| September 02, 2026 | 16.15B |
| September 01, 2026 | 15.88B |
| August 31, 2026 | 16.18B |
| August 28, 2026 | 16.36B |
| August 27, 2026 | 16.67B |
| August 26, 2026 | 16.88B |
| August 25, 2026 | 16.74B |
| August 24, 2026 | 16.90B |
| August 21, 2026 | 16.92B |
| August 20, 2026 | 16.70B |
| August 19, 2026 | 16.58B |
| August 18, 2026 | 16.08B |
| August 17, 2026 | 16.27B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| IQVIA Holdings, Inc. | 59.33B |
| Champions Oncology, Inc. | 74.82M |
| Avantor, Inc. | 15.09B |
| Personalis, Inc. | 1.514B |
| Adaptive Biotechnologies Corp. | 4.252B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 137.46M |
| Revenue (Quarterly) | 716.00M |
| Total Expenses (Quarterly) | 578.54M |
| EPS Diluted (Quarterly) | 4.845 |
| Gross Profit Margin (Quarterly) | 30.35% |
| Profit Margin (Quarterly) | 19.20% |
| Earnings Yield | 2.68% |
| Operating Earnings Yield | 3.14% |
| Normalized Earnings Yield | 2.676 |